JPWO2020017629A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020017629A5 JPWO2020017629A5 JP2020531380A JP2020531380A JPWO2020017629A5 JP WO2020017629 A5 JPWO2020017629 A5 JP WO2020017629A5 JP 2020531380 A JP2020531380 A JP 2020531380A JP 2020531380 A JP2020531380 A JP 2020531380A JP WO2020017629 A5 JPWO2020017629 A5 JP WO2020017629A5
- Authority
- JP
- Japan
- Prior art keywords
- rgma
- ham
- inhibitor
- htlv
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022148180A JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
| JP2024061895A JP7703174B2 (ja) | 2018-07-19 | 2024-04-08 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
| JP2025100449A JP2025134820A (ja) | 2018-07-19 | 2025-06-16 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018135925 | 2018-07-19 | ||
| JP2018135925 | 2018-07-19 | ||
| PCT/JP2019/028431 WO2020017629A1 (ja) | 2018-07-19 | 2019-07-19 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022148180A Division JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020017629A1 JPWO2020017629A1 (ja) | 2021-08-02 |
| JPWO2020017629A5 true JPWO2020017629A5 (https=) | 2022-07-01 |
| JP7150286B2 JP7150286B2 (ja) | 2022-10-11 |
Family
ID=69163691
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020531380A Active JP7150286B2 (ja) | 2018-07-19 | 2019-07-19 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
| JP2022148180A Active JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
| JP2024061895A Active JP7703174B2 (ja) | 2018-07-19 | 2024-04-08 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
| JP2025100449A Pending JP2025134820A (ja) | 2018-07-19 | 2025-06-16 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022148180A Active JP7475011B2 (ja) | 2018-07-19 | 2022-09-16 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
| JP2024061895A Active JP7703174B2 (ja) | 2018-07-19 | 2024-04-08 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
| JP2025100449A Pending JP2025134820A (ja) | 2018-07-19 | 2025-06-16 | Ｈｔｌｖ－１関連脊髄症（ｈａｍ）治療又は予防剤、及びｈａｍの治療方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20210269535A1 (https=) |
| EP (2) | EP4656657A3 (https=) |
| JP (4) | JP7150286B2 (https=) |
| KR (1) | KR20210034055A (https=) |
| CN (4) | CN116785439A (https=) |
| AU (1) | AU2019306721B2 (https=) |
| BR (1) | BR112021000949A2 (https=) |
| CA (1) | CA3112511A1 (https=) |
| IL (1) | IL280257A (https=) |
| MX (1) | MX2021000732A (https=) |
| PE (2) | PE20260298A1 (https=) |
| PH (1) | PH12021550134A1 (https=) |
| SG (1) | SG11202100561QA (https=) |
| TW (2) | TW202408577A (https=) |
| WO (1) | WO2020017629A1 (https=) |
| ZA (1) | ZA202101113B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025070749A1 (ja) * | 2023-09-29 | 2025-04-03 | 田辺三菱製薬株式会社 | 脊髄又は脳の障害により引き起こされる疾患に伴う随伴症状の予防又は治療剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1442749A1 (en) * | 2003-01-31 | 2004-08-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system |
| WO2005087268A1 (ja) | 2004-03-11 | 2005-09-22 | Bioclues, Inc | 軸索再生促進剤 |
| US8962803B2 (en) | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| KR101635489B1 (ko) | 2008-09-02 | 2016-07-01 | 도레이 배터리 세퍼레이터 필름 주식회사 | 미세다공성 고분자막, 이 미세다공성 고분자막의 제조방법 및 전지 세퍼레이터 필름으로서의 이 미세다공성 고분자막의 사용 |
| JP5552630B2 (ja) | 2008-10-24 | 2014-07-16 | 学校法人 聖マリアンナ医科大学 | Ｈｔｌｖ−ｉ関連脊髄症を治療または予防するための医薬、およびｈｔｌｖ−ｉ関連脊髄症の患者に対する抗体療法の効果を試験する方法 |
| ES2555060T3 (es) | 2009-12-09 | 2015-12-28 | Mitsubishi Tanabe Pharma Corporation | Inhibidor de la activación de linfocitos T, composición farmacéutica que lo contiene y método de cribado de sustancias inhibidoras de la activación de linfocitos T |
| EP2665486B1 (en) * | 2011-01-18 | 2019-12-25 | Bioniz, LLC | Compositions for modulating gamma-c-cytokine activity |
| JP5963233B2 (ja) * | 2011-12-07 | 2016-08-03 | 学校法人 聖マリアンナ医科大学 | Ｈｔｌｖ−１関連脊髄症を治療または予防するための医薬および前記医薬を用いた抗体療法の治療効果の確認方法 |
| JP6310845B2 (ja) * | 2012-07-06 | 2018-04-11 | 学校法人 聖マリアンナ医科大学 | Ｈｔｌｖ−１関連脊髄症患者の治療方法および治療剤 |
| TW201617612A (zh) | 2014-09-10 | 2016-05-16 | 艾伯維德國有限及兩合公司 | 以ＲＧＭａ片段為主的診斷分析 |
| US10287346B2 (en) * | 2015-04-28 | 2019-05-14 | Mitsubishi Tanabe Pharma Corporation | RGMa binding protein and use thereof |
| US20190224339A1 (en) * | 2016-04-29 | 2019-07-25 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| EP3464372A1 (en) * | 2016-06-01 | 2019-04-10 | AbbVie Inc. | Anti-repulsive guidance molecule a (rgma) antagonistic antibodies for treating spinal cord injury and pain |
| JP6923215B2 (ja) * | 2016-08-03 | 2021-08-18 | 国立大学法人 鹿児島大学 | 抗ｈｔｌｖ−１剤、ｈｔｌｖ−１関連脊髄症（ｈａｍ／ｔｓｐ）治療薬 |
-
2019
- 2019-07-19 CN CN202310983277.XA patent/CN116785439A/zh active Pending
- 2019-07-19 JP JP2020531380A patent/JP7150286B2/ja active Active
- 2019-07-19 CN CN202310983220.XA patent/CN116942831A/zh active Pending
- 2019-07-19 BR BR112021000949-3A patent/BR112021000949A2/pt unknown
- 2019-07-19 MX MX2021000732A patent/MX2021000732A/es unknown
- 2019-07-19 KR KR1020217005032A patent/KR20210034055A/ko not_active Ceased
- 2019-07-19 CN CN201980048012.2A patent/CN112566664B/zh active Active
- 2019-07-19 AU AU2019306721A patent/AU2019306721B2/en active Active
- 2019-07-19 CN CN202310983521.2A patent/CN116850291A/zh active Pending
- 2019-07-19 US US17/261,480 patent/US20210269535A1/en active Pending
- 2019-07-19 TW TW112142583A patent/TW202408577A/zh unknown
- 2019-07-19 CA CA3112511A patent/CA3112511A1/en active Pending
- 2019-07-19 TW TW108125746A patent/TWI825131B/zh active
- 2019-07-19 PE PE2025002847A patent/PE20260298A1/es unknown
- 2019-07-19 SG SG11202100561QA patent/SG11202100561QA/en unknown
- 2019-07-19 WO PCT/JP2019/028431 patent/WO2020017629A1/ja not_active Ceased
- 2019-07-19 PE PE2021000080A patent/PE20211376A1/es unknown
- 2019-07-19 EP EP25202154.8A patent/EP4656657A3/en active Pending
- 2019-07-19 EP EP19838340.8A patent/EP3824907B1/en active Active
-
2021
- 2021-01-18 IL IL280257A patent/IL280257A/en unknown
- 2021-01-18 PH PH12021550134A patent/PH12021550134A1/en unknown
- 2021-02-18 ZA ZA2021/01113A patent/ZA202101113B/en unknown
-
2022
- 2022-09-16 JP JP2022148180A patent/JP7475011B2/ja active Active
-
2024
- 2024-04-08 JP JP2024061895A patent/JP7703174B2/ja active Active
-
2025
- 2025-06-16 JP JP2025100449A patent/JP2025134820A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124257T1 (el) | N-[4-ΦΘOPO-5-[[(2S,4S)-2-MEΘYΛO-4-[(5-MEΘYΛO-1,2,4-ΟΞAΔIAZOΛ-3-YΛO)MEΘOΞY]-l-ΠΙΠΕΡΙΔΥΛΟ]ΜΕΘΥΛΟ]ΘΕΙΑΖΟΛ-2-ΥΛΟ]ΑΚΕΤΑΜΙΔΙΟ ΩΣ ΑΝΑΣΤΟΛΕΑΣ OGA | |
| CN111601791A (zh) | Ezh2抑制剂及其药学上可接受的盐和多晶型物及其应用 | |
| SA521422143B1 (ar) | 15-pgdh مثبط | |
| EA202193015A1 (ru) | Ингибиторы cdk | |
| JP2017506627A5 (https=) | ||
| MY199409A (en) | N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors | |
| JP2017035491A5 (ja) | 頭蓋内出血の治療のための方法および装置 | |
| JP1735298S (ja) | 骨切り術用ウェッジ | |
| EA201490161A1 (ru) | Соединения - ингибиторы сигналинга, опосредуемого рецептором notch | |
| CN110062757A (zh) | 凝血因子XIa抑制剂及其用途 | |
| CN110114083A (zh) | 一种预防和治疗脂肪肝的方法 | |
| JP2016523260A5 (https=) | ||
| MA45984B1 (fr) | Polytherapie pour la copd | |
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| JP1735297S (ja) | 骨切り術用ウェッジ | |
| MX2020001531A (es) | Nuevos compuestos hetorociclicos como inhibidores de cdk8/19. | |
| CN109661395A (zh) | Pde4抑制剂 | |
| MX2019008181A (es) | Inhibidores selectivos hdac6, metodos de preparacion y aplicacion de los mismos. | |
| AR119159A1 (es) | Tratamientos de angioedema | |
| EA200801619A1 (ru) | Способ улучшения фармакокинетики ингибиторов интегразы вич (варианты), набор и фармацевтическая композиция (варианты) | |
| JPWO2020017629A5 (https=) | ||
| CN115666576A (zh) | 一种治疗和/或预防冠状病毒引发的疾病的化合物及其应用 | |
| EA202190452A1 (ru) | Ингибиторы cdk8/19 | |
| JP2017014205A5 (https=) | ||
| EP4079374A4 (en) | METHOD FOR SYNTHESIS OF CELOSIANIN II, METHOD FOR SYNTHESIS OF BETAXANTHIN, AMYLOID-ß POLYMERIZATION INHIBITOR OR THERAPEUTIC OR PROPHYLACTIC AGENT AGAINST ALZHEIMER'S DISEASE, AMYLOID PEPTIDE AGGREGATION INHIBITOR, AND PROTEIN ACTIVITY INHIBITOR HIV-1 ESA |